Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial

被引:5
|
作者
Lewis, Benjamin R. [1 ,2 ]
Byrne, Kevin [1 ]
Hendrick, John [1 ]
Garland, Eric L. [1 ]
Thielking, Paul [1 ]
Beck, Anna [1 ]
机构
[1] Univ Utah, Salt Lake City, UT USA
[2] Huntsman Mental Hlth Inst, 501 Chipeta Way, Salt Lake City, UT 84108 USA
来源
JOURNAL OF PSYCHEDELIC STUDIES | 2023年 / 7卷 / 01期
关键词
psilocybin; psychedelic therapy; cancer; group therapy; LIFE-THREATENING CANCER; PSILOCYBIN TREATMENT; ANXIETY; DEPRESSION;
D O I
10.1556/2054.2022.00222
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Psilocybin-assisted psychotherapy has demonstrated significant promise as a treatment for depression, anxiety, and existential distress associated with serious medical illness and has generally been employed on an individual basis, which presents challenges for scaling and resource availability. There are also compelling theoretical reasons to suggest that group-based formats-if utilized in a thoughtful fashion-might offer unique or enhanced therapeutic benefits for certain conditions or populations. The HOPE trial is an IRB-approved open-label feasibility and safety pilot study of psi-locybin enhanced group therapy in patients with a DSM-5 depressive disorder associated with a cancer diagnosis completed at the Huntsman Cancer Institute (HCI) in Salt Lake City, Utah (HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients with Cancer). We report here quali-tative survey-based data, impressions, and suggestions for group-based psychedelic-assisted therapy interventions based on our observations to inform future studies. Methods: Patients with a DSM-5 depressive disorder with an underlying cancer diagnosis were recruited from HCI by referral from oncology providers, palliative care, and social work. Following screening and consenting, 4-6 partici-pants per cohort (with three total cohorts) were enrolled in a protocol involving 3 120 min group preparatory sessions, a single high-dose (25 mg) group psilocybin session, and 3 subsequent group integration sessions. Primary clinical outcomes are still in process of data collection and analysis. Qualitative data was gathered from patient written reports and a survey administered at 2 weeks post intervention. Qualitative reports were also gathered from the therapist team at a post-study group process session. Findings: We report here results from a qualitative survey of participant experiences with group format study design, as well as impressions and guidelines for group format and group psychotherapeutic process to inform other studies pursuing group-based interventions in psychedelic therapy. Suggestions are provided for protocol design, screening processes, space considerations, therapist team structure, group process, music, timeline, as well as potential issues and challenges.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [1] Psychedelic-Assisted Group Therapy: A Systematic Review
    Trope, Alexander
    Anderson, Brian T.
    Hooker, Andrew R.
    Glick, Giancarlo
    Stauffer, Christopher
    Woolley, Joshua D.
    JOURNAL OF PSYCHOACTIVE DRUGS, 2019, 51 (02) : 174 - 188
  • [2] Psychedelic-Assisted Therapy
    Penn, Andrew
    Dorsen, Caroline G.
    Hope, Stephanie
    Rosa, William E.
    AMERICAN JOURNAL OF NURSING, 2021, 121 (06) : 34 - 40
  • [3] Psychedelic-assisted psychotherapy: hope and dilemma
    不详
    LANCET REGIONAL HEALTH-EUROPE, 2023, 32
  • [4] Psychedelic experiences in psychedelic-assisted therapy for depression
    Khan, Umair
    PHILOSOPHICAL PSYCHOLOGY, 2024,
  • [5] Is There a Right to Psychedelic-Assisted Therapy?
    Kopeikin, Zak A.
    AMERICAN JOURNAL OF BIOETHICS, 2025, 25 (01): : 80 - 83
  • [6] Mechanisms of integration in psychedelic-assisted therapy
    Coverdale, Nicole S.
    Cook, Douglas J.
    JOURNAL OF MILITARY VETERAN AND FAMILY HEALTH, 2023, 9 (05): : 38 - 55
  • [7] Psychedelic-assisted therapy: An overview for the internist
    Barnett, Brian S.
    Mauney, Erin E.
    King, Franklin
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2025, 92 (03) : 171 - 180
  • [8] THE CHANGING LANDSCAPE OF PSYCHEDELIC-ASSISTED THERAPY
    Harvey, R.
    Arunogiri, S.
    Castle, D.
    Daubney, M.
    Davey, C.
    Kisely, S.
    Lacey, C.
    Loo, C.
    Matta, G.
    Strauss, N.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2024, 58 : 117 - 118
  • [9] Patient safety in psychedelic-assisted therapy
    不详
    AUSTRALASIAN PSYCHIATRY, 2023, 31 (04) : 570 - 571
  • [10] INFORMED CONSENT IN PSYCHEDELIC-ASSISTED THERAPY
    Bradberry, Mazdak
    Appelbaum, Paul
    Gukasyan, Natalie
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 469 - 469